PCVX Return on Tangible Equity | VAXCYTE, INC.

VAXCYTE, INC. (PCVX) Return on Tangible Equity

2026-06-30: Return Tang Equity -38.59%.
2026-03-31: Return Tang Equity -31.59%.
2025-12-31: Return Tang Equity -28.55%.
2025-09-30: Return Tang Equity -22.72%.

Complete source-backed return tang equity history.

Available history: 2018-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-38.59%
2026-03-31	-31.59%
2025-12-31	-28.55%
2025-09-30	-22.72%
2025-06-30	-17.83%
2025-03-31	-15.93%
2024-12-31	-14.03%
2024-09-30	-14.85%
2024-06-30	-25.03%
2024-03-31	-22.02%
2023-12-31	-32.43%
2023-09-30	-21.35%
2023-06-30	-18.47%
2023-03-31	-25.93%
2022-12-31	-23.44%
2022-09-30	-48.43%
2022-06-30	-38.93%
2022-03-31	-32.78%
2021-12-31	-35.24%
2021-09-30	-30.15%
2021-06-30	-27.33%
2021-03-31	-25.48%
2020-12-31	-25.80%
2020-09-30	-22.83%
2020-06-30	-19.15%
2020-03-31	47.94%
2019-12-31	47.26%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-28.55%
2024-12-31	-14.03%
2023-12-31	-32.43%
2022-12-31	-23.44%
2021-12-31	-35.24%
2020-12-31	-25.80%
2019-12-31	47.26%
2018-12-31	51.08%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
CG Oncology, Inc. (CGON)	United States	$6.095B	-27.95
Scholar Rock Holding Corp (SRRK)	United States	$5.920B	-16.37
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
CRISPR Therapeutics AG (CRSP)		$5.390B	-11.68